An asthmatic pregnant woman with COVID-19: A case report study.

Autor:	Motlagh AJ; Department of Pediatrics, School of Medicine, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran., Esmaelzadeh Saeieh S; Department of Midwifery, School of Medicine, Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran., Parhigar O; MS, Midwifery ward, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran., Salehi L; Research center for Health, Safety and Environment, Department of Health Education & Promotion, Alborz University of Medical Sciences, Karaj, Iran.
Jazyk:	angličtina
Zdroj:	Respiratory medicine case reports [Respir Med Case Rep] 2020; Vol. 31, pp. 101296. Date of Electronic Publication: 2020 Nov 19.
DOI:	10.1016/j.rmcr.2020.101296
Abstrakt:	Background: COVID-19 represents with various clinical symptoms and infects the respiratory tract, throat, nose, and lung involvement can lead to severe lung disease and death., among asthmatic patients, infections can lead to deterioration. The severity, and prognosis of this disease are likely to be devasted in pregnant women with underlying diseases such as asthma. Case Presentation: We present an Asthmatic pregnant woman who infected with SARS-CoV-2 admitted to two hospitals in Iran. The patient's symptoms were dry coughs, dyspnea, and inability to speak, numbness, and fatigue. The initial examination indicated a body temperature of 37.9 °C, oxygen saturation (SPO2) 91%, partial pressure of oxygen (Pao2) was 25 mm Hg, respiratory rate (RR) of 20 breaths/minute (b/m), blood pressure of 100/60 mmHg, and pulse of 80 bpm (beat/minute) and fetal heart rate (FHR) = 167/min. The pregnancy terminated by Caesarean Section (C/S) due to fetal tachycardia, a healthy baby with normal range. Anthropometric characteristics were born. Our case had leukopenia and also revealed, elevated C-reactive protein and erythrocyte sedimentation rate. Our case received supportive care and antibiotic & antiviral therapy and was discharged within 8 days with a good general condition. Conclusions: The patient's condition improved after 8 days of hospitalization and the patient underwent appropriate clinical outcome in spite of underlying disease and infection with SARS-CoV-2. Competing Interests: Authors declared, there isn't any conflict of interest. (© 2020 Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu